scholarly article | Q13442814 |
P356 | DOI | 10.1080/17512433.2019.1598859 |
P698 | PubMed publication ID | 30907177 |
P50 | author | Michele Dal Bo | Q42703041 |
Giuseppe Toffoli | Q54252459 | ||
P2093 | author name string | Lorena Baboci | |
Federica Di Cintio | |||
Davide Busato | |||
Monica Mossenta | |||
P2860 | cites work | Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death | Q24293504 |
P433 | issue | 5 | |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 453-470 | |
P577 | publication date | 2019-04-14 | |
P1433 | published in | Expert Review of Clinical Pharmacology | Q15793519 |
P1476 | title | Novel immunotherapeutic approaches for hepatocellular carcinoma treatment | |
P478 | volume | 12 |
Q91230219 | A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer |
Q92977405 | Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities |
Q102141646 | Immunopathobiology and therapeutic targets related to cytokines in liver diseases |
Q92344153 | New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma |
Q90749815 | Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics |